No evidence for nano-specific toxicity
Although it has been suggested that nanoparticles should 'be tested individually' (Krug and Wick 2011) , we see no evidence that nano-specific toxic mechanisms exist (review: Donaldson and Poland 2013a) . For example, conventional particles induce toxicity via general mechanisms, such as oxidative stress and inflammation. So far, no convincing example has been published that particles below 100 nm exhibit a qualitative change with regard to mechanism of toxicity. Of course, a larger surface area, which is characteristic for smaller particles, may intensify interactions between particles and biological systems (Fubini et al. 2010; Donaldson et al. 2013b) . However, this is not indicative of a qualitative step, but rather a 'gradual magnification of the intrinsic hazard' (Donaldson and Poland 2013a) . Therefore, it does not seem to be justified to label all material or objects containing nanoparticles as hazardous.
Induction of oxidative stress and release of inflammatory cytokines
Numerous studies have meanwhile shown that some nanoparticles can induce oxidative stress and lead to the release of inflammatory cytokines. Of course, these are mechanisms that are also common for larger particles and numerous soluble compounds. Therefore, there is no benefit to publish further articles confirming these mechanisms in It is well known that nanotechnology offers enormous potential for technological advancement (Ariga et al. 2012a, b; Tong et al. 2012; Dreaden et al. 2012; Wang et al. 2012; Marchan 2012; Tozak et al. 2013; Stewart and Marchan 2012; Piacham et al. 2013) . Therefore, it is highly fortuitous that from the very beginning, toxicological research kept pace with the developments in the field of nanotechnology (Oberdorster et al. 2005 (Oberdorster et al. , 2007 Nel et al. 2006; Lewinski et al. 2008; Hardman 2006; Singh et al. 2006; Xia et al. 2008; Smart et al. 2006; Donaldson et al. 2004; Linse et al. 2007 ). Each year, we the editors at the Archives of Toxicology review all the articles that were published the previous years in our journal, paying particular attention to those in research areas that are currently most relevant and exciting, and which contribute to the further development of toxicological sciences. It was not surprising that a significant fraction of articles matching these criteria were on nanotoxicology. A systematic analysis, however, produced some surprising resultsnanotoxicology actually dominates the field of toxicology to a much higher degree than originally expected-six of the ten most cited articles focus on some aspect of nanotoxicology (Table 1 ). This ratio is almost similar to the fraction of submitted nanotoxicology articles. Therefore, we believe that our current title is justified in claiming a Zinc oxide nanoparticles increase levels of reactive oxygen species and stimulate the release of proinflammatory cytokines in mouse and human cell lines, as well as primary cells
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Inorganic arsenic causes p38 signaling and apoptosis in the mouse cerebrum Yen et al. (2011) 18 The aspect ratio (length/diameter) can be used to predict toxicity of fibers. For multi-wall carbon nanotubes, the aspect ratio was not associated with genotoxicity but with cytotoxicity
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A genotoxicity assay based on the detection of histone H2AX phosphorylation was used to study bisphenol A and bisphenol F in various cell lines. While bisphenol A was clearly negative, bisphenol F was genotoxic in HepG2 cells Workers in pathology wards exposed to formaldehyde have increased frequencies of chromosomal aberrations Santovito et al. (2011) 9 Fenvalerate causes germ cell apoptosis via Fas signaling Zhao et al. (2011) 9 TiO 2 nanoparticles were tested in mice for a possible induction of pulmonary irritation. However, irritation and inflammation potencies were low Novel biomarkers were tested in a cohort of 629 subjects to predict malignant mesothelioma Gube et al. (2011) 9 Nrf2 protects PC12 cells against MnCl 2 neurotoxicity Li et al. (2011) 8 vitro. However, more useful questions still not sufficiently answered include 'Which exposure scenarios would lead to sufficiently high concentrations to activate oxidative stress and cytokine release in vivo? What is the margin of safety compared to doses that would cause adverse effects?'
Biodistribution, toxicokinetics and accumulation
Relatively little data especially with respect to long-term exposures are available concerning biodistribution and toxicokinetics (Aggarwal et al. 2009; Estevanato et al. 2012; Menjoge et al. 2010; Garza-Ocanas et al. 2010; Katsnelson et al. 2011) . Meanwhile, some general principles have been convincingly demonstrated. After intravenous application, gold nanoparticles are mostly found in the reticuloendothelial system in the liver, spleen, lymph nodes and bone marrow (Almeida et al. 2011) . Larger gold nanoparticles are efficiently taken up by the liver, whereas smaller nanoparticles may target other organs (Almeida et al. 2011) . The size of nanoparticles also influences their route of excretion. Furthermore, protein adsorption to the surface of nanoparticles, in addition to the surface charge and shape of nanoparticles, has been shown to influence pharmacokinetics. Nevertheless, relatively little is known about the biodistribution of nanoparticles in humans in vivo. The central question of interest is whether nanoparticles accumulate in organs or specific cell types to a degree that induce adverse effects. To answer this question, longterm studies are needed.
Role of immune cells
It has been convincingly shown that some nanoparticles can accumulate in immune cells, such as macrophages (Buono et al. 2009; Arnida et al. 2011; Lunov et al. 2011; Fedeli et al. 2013; Gasparotto et al. 2013) . However, the degree of accumulation that occurs in humans after NP exposure is unknown. Other open questions include whether the accumulation of nanoparticles in immune cells results in immunotoxicity and how large is margin of safety.
Grouping of nanoparticles for risk evaluation
A final highly relevant question is whether we can group nanomaterials according to their mode of action. Such a grouping will substantially facilitate the risk evaluation process. The coming years will show whether a consensus on a mechanism or mode of action-based classification system can be achieved.
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